Cardiovascular Flashcards
What 3 conditions make up ACS?
- ST elevation myocardial infarction (STEMI)
- Non-ST elevation myocardial infarction (NSTEMI)
- Unstable angina- no elevated troponin differentiates from NSTEMI
How to differentiate unstable angina from NSTEMI?
No elevated troponin in NSTEMI
Signs and symptoms of ACS?
Chest pain- central/left sided, radiate to jaw or left arm, heavy
Diabetics, elderly or female may not experience chest pain
Dyspnoea
Sweating
Nausea and vomiting
Palpitations
Pale and clammy
ACS investigations?
ECG
Cardiac markers- troponin
ECG and coronary territories?
Anterior- leads V1-V4, left anterior descending artery
Inferior- leads II, III, aVF, right coronary artery
Lateral- I, V5-6, left circumflex artery
ACS treatment?
Morphine
Oxygen- if under 94%
Nitrates- caution if hypotensive
Aspirin
For STEMI further management:
Clopidogrel or ticagrelor as well as aspirin
Percutaneous coronary intervention (PCI)- catheter in radial or femoral artery
ACS secondary prevention?
Aspirin
Second anti-platelet- clopidogrel, ticagrelor
Beta blocker
ACEi
Statin
STEMI criteria on an ECG?
Clinical symptoms consistent with ACS (generally of ≥ 20 minutes duration) with persistent (> 20 minutes) ECG features in ≥ 2 contiguous leads of:
2.5 mm (i.e ≥ 2.5 small squares) ST elevation in leads V2-3 in men under 40 years, or ≥ 2.0 mm (i.e ≥ 2 small squares) ST elevation in leads V2-3 in men over 40 years
1.5 mm ST elevation in V2-3 in women
1 mm ST elevation in other leads
New LBBB (LBBB should be considered new unless there is evidence otherwise)
What are the two types of coronary reperfusion therapy?
Percutaneous coronary intervention (PCI)
Fibrinolysis
Criteria for PCI?
Should be offered if the presentation is within 12 hours of the onset of symptoms and PCI can be delivered within 120 minutes of the time when fibrinolysis could have been given
If present after 12 hours PCI still to be considered
Radial access preferred using a drug eluting stent
Criteria for fibrinolysis?
Should be offered within 12 hours of the onset of symptoms if primary PCI cannot be delivered within 120 mins of the time when fibrinolysis could have been given
Further drugs PCI?
Dual therapy- aspirin + another drug
No oral anticoagulant- prasugrel
Oral anticoagulant- clopidogrel
PCI through radial- unfractionated heparin with bailout GPI
PCI through femoral- bivalirudin with bailout GPI
Fibrinolysis further drugs?
Patients undergoing fibrinolysis should be given an antithrombin drug
ECG to be repeated after 60-90 mins to see if ECG changes resolved. If persistent myocardial ischemia following fibrinolysis then PCI should be consisdered
NSTEMI further management?
Further drug therapy (after aspirin)-
Fondaparinux offered to patients not high bleeding risk or having angiography immediately
If immediate angiography planned unfractionated heparin given
Risk assessment (GRACE)
Low risk- ticagrelor
High risk- PCI, prasugrel or ticagrelor, unfractionated heparin
NSTEMI risk assessment score example?
GRACE
age
heart rate, blood pressure
cardiac (Killip class) and renal function (serum creatinine)
cardiac arrest on presentation
ECG findings
troponin levels
Reasons for coronary angiography in NSTEMI?
Clinically unstable (hypotensive)
Within 72 hours GRACE score above 3%
Myocardial infarction complications?
Cardiac arrest
Cardiogenic shock
Chronic heart failure
Tachyarrythmias- ventricular fibrillation most common cause of death
Bradyarrythmias- AV block following inferior MI
Pericarditis- in first 48 hours, Dressler’s syndrome 2-4 weeks after MI.
Left ventricular aneurysm
Acute mitral regurgitiation
**Left ventricular free wall rupture
Ventricular septal defect
Dressler’s syndrome?
2-6 weeks after MI, autoimmune reaction to proteins formed from myocardium recovery.
Fever, pleuritic pain, pericardial effusion and raised ESR. Treated with NSAIDs.
Secondary prevention after MI?
All patients offered:
Dual antiplatelet therapy (aspirin + 1)
ACEi
Beta blocker
Statin
Lifestyle:
Diet
Exercise
Sexual activity 4 weeks after MI
What is the screening for AAA?
A single abdominal ultrasound for males at 65 years old
<3cm- normal
3-4.4cm Small aneurysm- rescan in 12 months
4.5-5.4cm medium aneurysm- rescan every 3 months
>5.5cm large- refer within 2 weeks for surgical intervention
Management after AAA screening?
Low rupture risk- <5.5cm:
US surveillance and manage risk factors
High rupture risk:
Symptomatic, aortic diameter >5.5cm or rapidly enlarging >1cm per year
Refer within 2 week to vascular surgery
Treat with elective EVAR or open repair.
Risk factors for AAA?
Male
Age
Smoking
Hypertension
Rare:
Marfan’s
Ehlers Danlos
Syphillis
Ruptured aortic aneurysm?
Very high mortality of 80%
Features:
Severe, central abdominal pain radiating to the back
Pulsatile, expansile mass in the abdomen
Patients may be shocked (hypotension, tachycardia) or may have collapsed
Management:
Surgical emergency- immediate vascular review with a view to emergency repair
Clinical diagnosis in haemodynamically unstable
Haemodynamically stable can havev CT angiogram if diagnosis in doubt
6 P’s of critical limb ischaemia?
Pain
Pallor
Pulseless
Paralysis
Paraesthesia
Perishingly cold
Leriche syndrome?
Thick buttock pain
Absent femoral pulses
Male impotence
Blockage of distal aorta
What are the three main patterns of presentation seen in peripheral arterial disease?
Intermittent claudication
Critical limb ischaemia
Acute limb-threatening ischaemia